1 ABSTRACT
Objectives To review the literature from 2011 until March 31st, 2020 to identify the risk of transmission of ARIs to healthcare workers caring for patients undergoing AGMPs compared with the risk of transmission when caring for patients not undergoing AGMPs.
Results Only two prospective cohort studies were identified meeting inclusion criteria. One found that performance or assistance with AGMP during the previous week was significantly associated with symptomatic influenza (adjusted OR: 2.29, 95% CI: 1.3 to 4.2). The second study found that performance of AGMP was significantly associated with clinical respiratory infections (RR 2.9, 95% CI 1.42-5.87, p<0.01), laboratory-confirmed virus or bacteria (RR 2.9, 95% CI 1.37-6.22, p=0.01), and laboratory-confirmed virus (RR 3.3, 95% CI 1.01-11.02, p=0.05). Further evidence is needed regarding what constitutes an AGMP and the risk of ARI transmission during presumed AGMPs. Organizations need to interpret these findings with caution when establishing AGMP lists requiring airborne precautions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The SPOR Evidence Alliance (SPOR EA) is supported by the Canadian Institutes of Health Research (CIHR) under the Strategy for Patient-Oriented Research (SPOR) initiative. COVID-19 Evidence Network to support Decision-making (COVID-END) is supported by the Canadian Institutes of Health Research (CIHR) through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding opportunity.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Mark Hofmeister, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, mrhofmei{at}ucalgary.ca
Liza Mastikhina, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, lmastikh{at}ucalgary.ca
John Taplin, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, jgtaplin{at}ucalgary.ca
Tom Noseworthy, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, tnosewor{at}ucalgary.ca
Joyce Li, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, joycli{at}ucalgary.ca
Brenlea Farkas, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, brenlea.farkas{at}ucalgary.ca
Laura Dowsett, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, lelegget{at}ucalgary.ca
Fiona Clement, 3D10, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, fclement{at}ucalgary.ca
Funding Statement: The SPOR Evidence Alliance (SPOR EA) is supported by the Canadian Institutes of Health Research (CIHR) under the Strategy for Patient-Oriented Research (SPOR) initiative.
COVID-19 Evidence Network to support Decision-making (COVID-END) is supported by the Canadian Institutes of Health Research (CIHR) through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding opportunity.
Data Availability
All datasets supporting the conclusions of this article are included within the article
LIST OF ABBREVIATIONS
- AGMPs
- aerosol-generating medical procedures
- ARIs
- acute respiratory infections
- CDC
- Center for Disease Control and Prevention
- HCWs
- healthcare workers
- ICUs
- intensive care units
- IPC
- infection prevention and control
- OR
- odds ratio
- PPE
- personal protective equipment
- RCT
- randomized control trial
- RR
- relative risk
- SARS
- severe acute respiratory syndrome WHO World Health Organization